rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lawrence G. Miller

Director

Company insider

Files Form 4 as: Director, Apnimed.

In numbers

Trades disclosed
60
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
3 Aug 2026
Last trade
3 Aug 2026
Last filed
3 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
APMD ApnimedDirector · Biotechnology · last 3 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code D—92,431filing
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code D—88,954filing
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code A—88,954filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code C—10,845 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—688,042 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—688,042 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—98,843 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—98,843 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—302,541 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—302,541 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code A—92,431filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—333,580 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—59,303 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—59,303 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—25,574 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Alpha Wave Ventures GP, Ltd10% owner · 10% owner at Apnimed, filing Form 4 there in the last year
Morningside Venture Investments Ltd10% owner · 10% owner at Apnimed, filing Form 4 there in the last year
Kevin Robert LindDirector · Chief Executive Officer at Apnimed, filing Form 4 there in the last year
Paul R. FonteyneDirector · Director at Apnimed, filing Form 4 there in the last year
Dennis Patrick MolnarPresident · President at Apnimed, filing Form 4 there in the last year